{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:13:57Z","timestamp":1761581637985},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009427","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T02:41:16Z","timestamp":1513910476000},"page":"e9427","source":"Crossref","is-referenced-by-count":10,"title":["Impact of metformin on serum prostate-specific antigen levels"],"prefix":"10.1097","volume":"96","author":[{"given":"Jee Soo","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Sik","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Ha","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo Chul","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-157-20210226","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rates","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"R2-157-20210226","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"R3-157-20210226","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/aje\/kwp003","article-title":"Association of diabetes with prostate cancer risk in the multiethnic cohort","volume":"169","author":"Waters","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R4-157-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clgc.2014.01.001","article-title":"Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms","volume":"12","author":"Rastmanesh","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"R5-157-20210226","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.53.4.1052","article-title":"Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?","volume":"53","author":"Brunmair","year":"2004","journal-title":"Diabetes"},{"key":"R6-157-20210226","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res"},{"key":"R7-157-20210226","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/annonc\/mdr037","article-title":"Metformin in prostate cancer: two for the price of one","volume":"22","author":"Clements","year":"2011","journal-title":"Ann Oncol"},{"key":"R8-157-20210226","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.urolonc.2016.10.009","article-title":"A review for clinicians: prostate cancer and the antineoplastic properties of metformin","volume":"35","author":"Hankinson","year":"2017","journal-title":"Urol Oncol"},{"key":"R9-157-20210226","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/pros.23228","article-title":"The relationship between metformin and serum prostate-specific antigen levels","volume":"76","author":"Jayalath","year":"2016","journal-title":"Prostate"},{"key":"R11-157-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21681805.2016.1271353","article-title":"Antidiabetic drug use and prostate cancer risk in the Finnish randomized study of screening for prostate cancer","volume":"51","author":"Haring","year":"2017","journal-title":"Scand J Urol"},{"key":"R12-157-20210226","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/1876822901306010010","article-title":"Dutasteride and metformin reduce the growth of LNCaP cells and alter the SREBP-1 pathway","volume":"6","author":"Besla","year":"2013","journal-title":"Open Prostate Cancer J"},{"key":"R13-157-20210226","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/pcan.2012.16","article-title":"Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer","volume":"15","author":"Colquhoun","year":"2012","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R14-157-20210226","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.canlet.2014.09.001","article-title":"SMILE upregulated by metformin inhibits the function of androgen receptor in prostate cancer cells","volume":"354","author":"Lee","year":"2014","journal-title":"Cancer Lett"},{"key":"R15-157-20210226","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/pros.23000","article-title":"Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor","volume":"75","author":"Wang","year":"2015","journal-title":"Prostate"},{"key":"R16-157-20210226","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: a meta-analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"key":"R17-157-20210226","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","article-title":"A meta-analysis of diabetes mellitus and the risk of prostate cancer","volume":"15","author":"Kasper","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R18-157-20210226","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10552-011-9770-3","article-title":"The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series","volume":"22","author":"Moreira","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R19-157-20210226","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10552-010-9530-9","article-title":"History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study","volume":"21","author":"Li","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R20-157-20210226","doi-asserted-by":"crossref","first-page":"E541","DOI":"10.1111\/j.1464-410X.2012.11232.x","article-title":"Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment","volume":"110","author":"Garc\u00eda-Cruz","year":"2012","journal-title":"BJU Int"},{"key":"R21-157-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrclinonc.2016.120","article-title":"Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?","volume":"14","author":"Klil-Drori","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"R22-157-20210226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/pcan.2012.40","article-title":"Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies","volume":"16","author":"Bansal","year":"2013","journal-title":"Prostate Cancer Prostat Dis"},{"key":"R23-157-20210226","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2337\/dc10-1640","article-title":"Diabetes and risk of prostate cancer: a study using the National Health Insurance","volume":"34","author":"Tseng","year":"2011","journal-title":"Diabetes Care"},{"key":"R24-157-20210226","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.7314\/APJCP.2012.13.8.4097","article-title":"Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis","volume":"13","author":"Long","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"R25-157-20210226","doi-asserted-by":"crossref","first-page":"e116327","DOI":"10.1371\/journal.pone.0116327","article-title":"Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"R26-157-20210226","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/dmrr.2645","article-title":"Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis","volume":"31","author":"Deng","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"R27-157-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nature16151","article-title":"Depletion of fat-resident Treg cells prevents age-associated insulin resistance","volume":"528","author":"Bapat","year":"2015","journal-title":"Nature"},{"key":"R28-157-20210226","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"R29-157-20210226","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.eururo.2014.04.027","article-title":"Metformin use and prostate cancer risk","volume":"66","author":"Preston","year":"2014","journal-title":"Eur Urol"},{"key":"R30-157-20210226","doi-asserted-by":"crossref","first-page":"945","DOI":"10.7326\/0003-4819-140-11-200406010-00035","article-title":"The evolving diabetes burden in the United States","volume":"140","author":"Engelgau","year":"2004","journal-title":"Ann Intern Med"},{"key":"R31-157-20210226","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","article-title":"Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark","volume":"89","author":"Wideroff","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R32-157-20210226","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/jnci\/djg105","article-title":"Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden","volume":"95","author":"Zendehdel","year":"2003","journal-title":"J Natl Cancer Inst"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:49:22Z","timestamp":1620960562000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712220-00157"}},"subtitle":["Data from the national health and nutrition examination survey 2007 to 2008"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":31,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009427","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}